3 Penny Stocks to Watch Under $1 in December
With December here, penny stocks continue to show renewed momentum. Although trading both penny stocks and blue chips has been difficult in the last few months and especially the past week or so, investors are eager to find small-caps that could see bullish momentum.
To do so, we first have to understand exactly what’s affecting the stock market and how to take advantage. As we all know, right now, the largest impacting factor on stocks is the Omicron variant of Covid-19. While the variant is still little understood, early figures are showing encouraging signs that could help to relieve fears.
News out of Israel is also showing that current vaccines, which were feared to have a reduced effect on Omicron, could still hold up to the task of protecting us. In addition, anecdotal evidence is showing that the variant could cause less severe symptoms than previous variants. So, while we are not out of the woods yet, we can use this information to find the best penny stocks to buy. With all of that in mind, let’s take a look at three to watch right now.
3 Under $1 Penny Stocks to Watch Right Now
- Borqs Technologies Inc. (NASDAQ: BRQS)
- Agile Therapeutics Inc. (NASDAQ: AGRX)
- Adamis Pharmaceuticals Corp. (NASDAQ: ADMP)
Borqs Technologies Inc. (NASDAQ: BRQS)
Borqs Technologies Inc. is a technology penny stock that develops smart device and cloud service solutions. BorqsWare, the company’s software platform that comprises the BorqsWare client software, is utilized in Android phones, tablets, watches, and other devices. This company’s goods are sold to a variety of customers, including mobile chip designers and mobile device equipment manufacturers.
On November 8th, the company was granted land-use rights for 5G/Internet of Things (IoT) solutions. Its wholly-owned subsidiary Borqs Hong Kong Limited was granted land-use rights for around 1.4 million sq. ft. in Huzhou, China, which is located in the Yangtze River Delta. This is one of the fastest-growing industrial regions in the world. These land-use rights are valued at $10.5 million and will be developed in two phases. The total construction space is expected to be 2.2 million sq. ft. and will cost about $125 million.
In the last five days, BRQS stock has increased by a solid 9%. This represents a decent bullish turnaround from its previous yearly performance. While shares are no where near its YTD high of almost $3 at its current price of $0.55, the positive sentiment is encouraging. Noting this recent advancement, will BRQS be on your penny stock watchlist next month?
Agile Therapeutics Inc. (NASDAQ: AGRX)
Agile Therapeutics Inc. is a biotech penny stock that has seen momentum during the last few trading days. One of the reasons behind this could be the emphasis on biotech stocks as a result of the Omicron Covid variant. For some context, this corporation produces prescription contraceptives for women. Agile is involved in the product’s research, development, and marketing. Twirla, its principal product, is a weekly prescription contraceptive patch. It is also working on Twirla line expansions and other products.
At the start of November, Agile reported its third-quarter financial results for 2021. During this period, Agile delivered $1.3 million in net product sales in total. Its cost of product revenues came in at $2.7 million, including a $1.4 million reserve for inventory not expected to be sold before its shelf-life date. The company’s total operating expenses went down by $0.3 million year over year. In total, Agile’s R&D expenses fell to $1.6 million from $3.7 million the previous year.
“We are encouraged by solid double-digit growth in prescription demand as measured by cycles dispensed. We are excited that the quarterly prescription growth came from both new prescriptions and refills. Our goal is to continue to accelerate growth for the Twirla brand and reduce our time to profitability.”The Chairman and Chief Executive Officer of Agile, Al Altomari
On November 30th, AGRX stock increased by over 15% before correcting. However, shares are sitting at a comfortable $0.63 as of Wednesday morning on December 1st. Based on this recent momentum, will AGRX be on your list of penny stocks to watch next month?
Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)
Adamis Pharmaceuticals Corporation is another popular biotech penny stock that has seen decent bullish momentum in the last few trading days. One of its flagship products, the Symjepi Injection, is a pre-filled syringe product that is in use to treat acute allergic responses such as anaphylaxis. It is also working on APC410, which will be used to treat respiratory illnesses such as asthma, influenza, and COVID-19.
On November 22nd, the company released its third-quarter financial results for 2021. It announced that its revenues for the nine months ended September 30th, 2021 and 2020 were $3.4 million and $2.1 million respectively. This increase in revenue is the result of the US WorldMeds marketing initiatives for SYMJEPI. Its general and administrative expenses grew year over year as well, as did its research and development costs.
“Adamis made significant advancements over the past year. We resubmitted our NDA for ZIMHI to the FDA. We initiated and began enrolling patients in a Phase 2/3 clinical trial to evaluate the use of Tempol for the treatment of COVID-19. Under our new commercial partner, we have seen significant sales growth for SYMJEPI.”President and CEO of Adamis, Dennis J. Carlo, Ph.D.
Despite negative performance in the last month, ADMP stock has gained over 50% in the YTD period. Based on all of this info, will ADMP make your list of penny stocks to watch?
Which Penny Stocks Are You Watching Right Now?
If you’re looking for the best penny stocks to buy, there are hundreds of options to choose from. Although it can be overwhelming considering the long list of penny stocks that are out there, with proper information and a commitment to a trading strategy, making money with penny stocks can be easier than previously imagined. Considering all of this, which penny stocks are you watching as we move into December 2021?